Ausgabe 3/2022
Inhalt (14 Artikel)
I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response
Donika Plyku, Robert F. Hobbs, Di Wu, Carlos Garcia, George Sgouros, Douglas Van Nostrand
Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab
Florian Eude, Florian Guisier, Mathieu Salaün, Luc Thiberville, Thibault Pressat-Laffouilhere, Pierre Vera, Pierre Decazes
Feasibility of 125I-RGD uptake as a marker of angiogenesis after myocardial infarction
Takafumi Yamase, Junichi Taki, Hiroshi Wakabayashi, Anri Inaki, Tomo Hiromasa, Hiroshi Mori, Norihito Akatani, Kazuma Ogawa, Kazuhiro Shiba, Seigo Kinuya
Serial change in perfusion–metabolism mismatch after coronary artery bypass grafting
Motoko Morishima, Tomonari Kiriyama, Yasuo Miyagi, Toshiaki Otsuka, Yoshimitsu Fukushima, Shin-ichiro Kumita, Yosuke Ishii
Correction to: Serial change in perfusion–metabolism mismatch after coronary artery bypass grafting
Motoko Morishima, Tomonari Kiriyama, Yasuo Miyagi, Toshiaki Otsuka, Yoshimitsu Fukushima, Shin-ichiro Kumita, Yosuke Ishii
Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma
Kun-Han Lue, Sung-Chao Chu, Ling-Yi Wang, Yen-Chang Chen, Ming-Hsun Li, Bee-Song Chang, Sheng-Chieh Chan, Yu-Hung Chen, Chih-Bin Lin, Shu-Hsin Liu
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma
Anri Inaki, Tohru Shiga, Yoshito Tsushima, Megumi Jinguji, Hiroshi Wakabayashi, Daiki Kayano, Norihito Akatani, Takafumi Yamase, Yuji Kunita, Satoru Watanabe, Tomo Hiromasa, Hiroshi Mori, Kenji Hirata, Shiro Watanabe, Tetsuya Higuchi, Hiroyasu Tomonaga, Seigo Kinuya
Validity of the γ-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test
Yoshiaki Miyazaki, Masashi Kameyama, Akira Nakamizo, Tomoyuki Noguchi, Nobuyuki Tabata
A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from LNs data of 20 esophageal cancer patients
Miwako Takahashi, Shuntaro Yoshimura, Sodai Takyu, Susumu Aikou, Yasuhiro Okumura, Koichi Yagi, Masashi Fukayama, Toshimitsu Momose, Yasuyuki Seto, Taiga Yamaya
Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging
Katharina Kessel, Robert Seifert, Matthias Weckesser, Martin Boegemann, Sebastian Huss, Clemens Kratochwil, Uwe Haberkorn, Frederik Giesel, Kambiz Rahbar
Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study
Tomoaki Otani, Tsuneo Saga, Takayoshi Ishimori, Eitaro Kidera, Yoichi Shimizu, Rihito Aizawa, Kiyonao Nakamura, Takayuki Goto, Shusuke Akamatsu, Takashi Mizowaki, Yuji Nakamoto
Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses
Ayşegül Aksu, Özge Vural Topuz, Gülşah Yılmaz, Gamze Çapa Kaya, Burçak Yılmaz
Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo
Yoichi Shimizu, Sho Koyasu, Mari Suzukida, Kiyotaka Izumi, Eitaro Kidera, Takero Shindo, Tsuneo Saga, Masahiro Ono, Akifumi Takaori-Kondo, Yuji Nakamoto